Fig. 1

Comparison of HOMA-IR indexes distribution across the body mass index categories in various groups. a Proportion of patients whose homeostasis model assessment insulin resistance (HOMA-IR) was higher than 2.7 in health control (HC) group, chronic hepatitis B (CHB) group, nonalcoholic fatty liver disease (NAFLD) group and CHB with NAFLD group, respectively. b Proportion of patients whose HOMA-IR > 2.7 with body mass index (BMI) ≥ 25 kg/m² and < 25 kg/m² in HC, CHB, NAFLD and CHB with NAFLD group, respectively. c HOMA-IR indexes distribution of patients in HC, CHB, NAFLD and CHB with NAFLD Group, respectively. d HOMA-IR indexes distribution of patients with BMI ≥ 25 kg/m² and < 25 kg/m² in HC, CHB, NAFLD and CHB with NAFLD Group, respectively. ***P < 0.001